journal article·2026-06Open access

Complement-inflammation inhibition via stealth nanomedicine for mild thermo-responsive postoperative on-demand pain management

Xinye Song, Miao Feng, Jiaju Zhao, Guokai Wu, Mengmeng Bai, Yuanli Luo, Bin Qiao, Yong Luan

Abstract

Complement- and inflammation-cascade activation-induced clearance of nanomedicines severely limits their efficacy in postoperative pain management. Here, we report a stealth nanomedicine (LMIBP) designed to directly address this challenge, enabling mild, on-demand, thermoresponsive pain relief via inhibition of complement-mediated inflammation. LMIBP integrates ginsenoside Rg3-modified stealth liposomes with dendritic mesoporous silica nanoparticles (DMSNs) loaded with indocyanine green (ICG), perfluoropentane (PFP), and levobupivacaine. Rg3 replaces PEG and cholesterol to suppress complement C3 activation, reduce pro-inflammatory cytokine production, and promote M2 macrophage polarization, thereby extending in vivo retention time by evading immune clearance. Under mild Near-infrared (NIR) light irradiation, ICG generates localized heat with a moderate thermal effect to avoid tissue damage and trigger PFP's liquid-to-gas phase transition, thereby forming microbubbles for ultrasound imaging guidance and accelerating levobupivacaine release. In the preclinical incision pain model, LMIBP prolongs analgesia and enables on-demand reactivation with repeated NIR without neurotoxicity or inflammation. This work pioneers complement-inflammation inhibition as a core design principle for stealth nanomedicines, providing a clinically translatable strategy for ultrasound-guided, mild thermo-responsive on-demand postoperative pain management.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Anesthesia and Pain Management · Pain Mechanisms and Treatments · Vagus Nerve Stimulation Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (65)

Show source-provided references
1. Enhancing pediatric postoperative pain management: strategies, challenges, and innovations – a comprehensive review and observational study10.1097/JS9.0000000000001585 ↗
2. Patient reported outcome of adult perioperative anaesthesia in the United Kingdom: a cross-sectional observational study10.1093/bja/aew381 ↗
3. Acute pain management in people with opioid use disorder: a systematic review10.7326/ANNALS-24-01917 ↗
4. Nociplastic pain: towards an understanding of prevalent pain conditions10.1016/S0140-6736(21)00392-5 ↗
5. Opportunities for chronic pain self-management: core psychological principles and neurobiological underpinnings10.1016/S0140-6736(25)00404-0 ↗
6. New advances in acute postoperative pain management10.1007/s11916-018-0690-8 ↗
7. Management of opioid-tolerant patients with acute pain: approaching the challenges10.1007/s40265-019-01236-4 ↗
8. Artificial nano-red blood cells nanoplatform with lysosomal escape capability for ultrasound imaging-guided on-Demand pain management10.1016/j.actbio.2023.01.004 ↗
9. Intensity-adjustable pain management with prolonged duration based on phase-transitional nanoparticles-assisted ultrasound imaging-guided nerve blockade10.1186/s12951-022-01707-z ↗
10. Highly‐sensitive implantable NIR phototransistor for one‐click pain relief activation10.1002/adma.202507725 ↗
11. Piezoelectric analgesia blocks cancer‐induced bone pain
12. Ultrasound-triggered local anaesthesia10.1038/s41551-017-0117-6 ↗
13. Engineering 2D silicene‐based mesoporous nanomedicine for in vivo near‐infrared‐triggered analgesia10.1002/advs.202202735 ↗
14. Light-triggered release of conventional local anesthetics from a macromolecular prodrug for on-Demand local anesthesia
15. Artificial nanotargeted cells with stable photothermal performance for multimodal imaging-guided tumor-specific therapy10.1021/acsnano.0c00771 ↗
16. Protein-activatable diarylethene monomer as a smart trigger of noninvasive control over reversible generation of singlet oxygen: a facile, switchable, Theranostic strategy for photodynamic-immunotherapy10.1021/jacs.0c12851 ↗
17. Biomimetic nanosystems harnessing NIR-II photothermal effect and hypoxia-responsive prodrug for self-amplifying and synergistic tumor treatment10.1016/j.nantod.2024.102395 ↗
18. Self-amplifying violet phosphorus-manganese nanocatalysts disrupt redox homeostasis and potentiate antitumor immunity via NIR-II phototherapy10.1016/j.biomaterials.2025.123872 ↗
19. Breaking apoptosis‐induced immune silence: ultrasound-activated nano‐oncolytic therapy reinvigorates antitumor immunity10.1002/adma.202508681 ↗
20. Iron homeostasis-regulated adaptive metabolism of PEGylated ultrasmall iron oxide nanoparticles10.1021/acsnano.5c01399 ↗
21. The benefits and risks of PEGylation in nanomedicine10.1038/s41565-025-01951-y ↗
22. High-density brush-shaped polymer lipids reduce Anti-PEG antibody binding for repeated administration of mRNA therapeutics
23. To PEGylate or not to PEGylate: immunological properties of nanomedicine's Most popular component, polyethylene glycol and its alternatives10.1016/j.addr.2021.114079 ↗
24. Red blood cell derived nanocarrier drug delivery system: a promising strategy for tumor therapy
25. Lipid-based nanoparticles: strategy for targeted cancer therapy10.15212/bioi-2024-0107 ↗
26. Adipose-derived leptin and complement factor D mediate osteoarthritis severity and pain10.1126/sciadv.adt5915 ↗
27. Targeting C1q prevents microglia-mediated synaptic removal in neuropathic pain10.1038/s41467-025-59849-1 ↗
28. C5a complement and cytokine signaling mediate the pronociceptive effects of complex regional pain syndrome patient IgM in fracture mice10.1097/j.pain.0000000000002150 ↗
29. The role and treatment potential of the complement pathway in chronic pain10.1016/j.jpain.2024.104689 ↗
30. Disrupting complement‐inflammation positive feedback circuit via oligonucleotide hydrogel microspheres for reversing joint inflammation
31. Conjugation of haloperidol to PEG allows peripheral localisation of haloperidol and eliminates CNS extrapyramidal effects10.1016/j.jconrel.2020.02.037 ↗
32. Inflammation-responsive nanoparticles suppress lymphatic clearance for prolonged arthritis therapy10.1016/j.jconrel.2022.11.005 ↗
33. Injectable in situ forming gel based on lyotropic liquid crystal for persistent postoperative analgesia10.1016/j.actbio.2017.11.057 ↗
34. Bone metastases in NSCLC: modern paradigms in management and supportive care
35. Paclitaxel-loaded ginsenoside Rg3 liposomes for drug-resistant cancer therapy by dual targeting of the tumor microenvironment and cancer cells10.1016/j.jare.2022.09.007 ↗
36. Pharmacological mechanisms and drug delivery systems of ginsenoside Rg3: a comprehensive review10.1016/j.phrs.2025.107799 ↗
37. Ginsenoside Rg3 endows liposomes with prolonged blood circulation and reduced accelerated blood clearance10.1016/j.jconrel.2023.10.023 ↗
38. Versatile ginsenoside Rg3 liposomes inhibit tumor metastasis by capturing circulating tumor cells and destroying metastatic niches10.1126/sciadv.abj1262 ↗
39. Optimizing chronic pain treatment: a summary of infrequently investigated therapeutic interventions for modulating pain
40. Smart‐responsive multifunctional therapeutic system for improved regenerative microenvironment and accelerated bone regeneration via mild photothermal therapy10.1002/advs.202304641 ↗
41. Mild photothermal‐stimulation based on injectable and photocurable hydrogels orchestrates immunomodulation and osteogenesis for high‐performance bone regeneration10.1002/smll.202300111 ↗
42. A multimodal imaging-guided nanoreactor for cooperative combination of tumor starvation and multiple mechanism-enhanced mild temperature phototherapy10.1039/D0BM01350A ↗
43. Mitochondrial glutathione depletion nanoshuttles for oxygen-irrelevant free radicals generation: a cascaded hierarchical targeting and Theranostic strategy against hypoxic tumor10.1021/acsami.1c24708 ↗
44. Light-responsible ECM-mimetic scaffolds for neural differentiation. Intracellular versus extracellular photothermal stimulation
45. Surgical tumor-derived personalized photothermal vaccine formulation for cancer immunotherapy10.1021/acsnano.8b07371 ↗
46. Bioinspired soft-hard combined system with mild photothermal therapeutic activity promotes diabetic bone defect healing via synergetic effects of immune activation and angiogenesis10.7150/thno.97335 ↗
47. Multifunctional injectable hydrogel system as a mild photothermal-assisted therapeutic platform for programmed regulation of inflammation and osteo-microenvironment for enhanced healing of diabetic bone defects In Situ10.7150/thno.102779 ↗
48. Ultrasound-guided regional anesthesia: current concepts and future trends10.1213/01.ane.0000260614.32794.7b ↗
49. Ultrasound guidance speeds execution and improves the quality of supraclavicular block10.1213/01.ANE.0000086730.09173.CA ↗
50. Ultrasound-guided supraclavicular brachial plexus block10.1213/01.ANE.0000062519.61520.14 ↗
51. Rebound pain after peripheral nerve block: a review10.1007/s40265-025-02196-8 ↗
52. Hirzallah · Crit. Care Med. · 2024 · 52 · 154310.1097/CCM.0000000000006345 ↗
53. Targeted ruthenium‐based anti‐inflammatory nanoagent for enhanced rheumatoid arthritis treatment10.1002/EXP.20240043 ↗
54. Key principles and methods for studying the endocytosis of biological and nanoparticle therapeutics10.1038/s41565-021-00858-8 ↗
55. Complement activation turnover on surfaces of nanoparticles10.1016/j.nantod.2017.03.001 ↗
56. Generation of C5a in the absence of C3: a new complement activation pathway10.1038/nm1419 ↗
57. Structural insights into the central complement component C310.1016/j.molimm.2006.06.017 ↗
58. Dual‐responsive multi‐functional silica nanoparticles with repaired mitochondrial functions for efficient alleviation of spinal cord injury10.1002/EXP.70012 ↗
59. Catalytic activity of violet phosphorus-based nanosystems and the role of metabolites in tumor therapy10.1038/s41467-024-50769-0 ↗
60. Engineered Manganese-BODIPY coordinated nanoadjuvants for enhanced NIR-II photo-metalloimmunotherapy10.1016/j.jconrel.2024.11.005 ↗
61. Innovations and advances in modelling and measuring pain in animals10.1038/s41583-021-00536-7 ↗
62. METTL14-Mediated m6A epitranscriptomic modification contributes to chemotherapy-induced neuropathic pain by stabilizing GluN2A expression via IGF2BP210.1172/JCI174847 ↗
63. Importin Α3 regulates chronic pain pathways in peripheral sensory neurons10.1126/science.aaz5875 ↗
64. Reactive oxygen species and neurodegenerative diseases: insights into nanozyme therapeutics
65. Nociception and pain in humans lacking a functional TRPV1 channel10.1172/JCI153558 ↗